Oral delivery of glucagon-like peptide-1 (GLP-1) peptides has the potential to improve patient convenience and adherence, but gastrointestinal degradation and…
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Discover how Lonza Capsugel helps you overcome durg product development challenges, accelerate timelines, and unlock new opportunities for innovation
This expert-led session explores the latest advancements in oral delivery systems for emerging drug modalities, with a particular focus on peptides and other complex…
Poster presentation delivered at the Controlled Release Society (CRS) Annual Meeting, 2025.
At the Innovaform® Accelerator, we’re commited to advancing drug delivery through collaboration and cutting-edge science.
Explore how Lonza’s advanced polymer science and capsule manufacturing capabilities - Capsugel® Enprotect® - have led to a breakthrough in enteric protection.
Unlocking the full potential of many therapies hinges on effective absorption in the lower GI tract. Yet, delivering fragile APIs to the right location is no small…
The lower gastrointestinal tract is critical for enhancing bioavailability and drug absorption, directly influencing therapeutic efficacy.
Enteric capsules have many applications. Their principal purpose is to prevent the release of active pharmaceutical ingredients (APIs) in the stomach and to avoid…
The lower GI tract plays an important role in how well drugs are absorbed and utilized by the body. But delivering sensitive APIs to this region—especially those…
The lower gastro-intestinal tract plays an important role in optimizing bio-availability and drug absorption – and therefore the effectiveness of many therapies. But…
These findings confirm that Capsugel® Enprotect® capsules offer a robust, scalable, & patient-friendly alternative to traditional double-encapsulation methods
This downloadable summary features findings from a peer-reviewed study evaluating the in vivo performance of Capsugel® Enprotect® capsules
深入对比传统包衣方法与新型双层聚合物技术,例如 Capsugel® Enprotect® 胶囊所采用的技术
Discover how Capsugel® Enprotect® capsule’s bi-layered polymer technology enables targeted enteric delivery—without the need for post-filling coating.
本产品规格手册概述了 Capsugel® Enprotect® 胶囊。It details the capsule’s composition, performance, data on dissolution,…
Capsugel® Enprotect® 是一种即用型肠溶胶囊,耐酸性高达 pH 6.0,无需填充后包衣。This scientific brochure…
  • 1 (current)
  • 2
联系我们
Powered by Translations.com GlobalLink Web Software